SENSEI BIOTHERAPEUTICS INC (SNSE)

US81728A1088 - Common Stock

1.26  +0.24 (+23.54%)

After market: 1.25 -0.01 (-0.79%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
37.06M50.19M37.49M18.72M12.43M
Research and Development
18.30M30.38M21.66M11.19M8.35M
Selling, General, and Administrative Expenses
18.77M19.81M15.82M7.53M4.09M
Operating Income
-37.06M-50.19M-37.49M-18.72M-12.43M
Interest Income/Expense
3.48M1.56M130.00K-690.00K-4.23M
Other Income/Expense
-215.00KN/A690.00K0.000.00
Non Recurring Items
N/A0.00570.00K-690.00K-80.00K
Income Before Taxes
-34.10M-48.59M-36.79M-20.10M-16.74M
Net Income
-34.10M-48.59M-36.79M-20.20M-20.54M
EBITDA
-35.71M-48.84M-36.80M-18.51M-12.36M
 
Per Share Data
EPS Diluted Total Ops
-1.22-1.58-1.33-0.68-0.70
Non GAAP EPS
-1.22-1.58-1.36N/AN/A
 
Statistics

All data in USD

Charts